Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Gynecologic CancerPost-operative Pain
Interventions
DRUG

Bupivicaine

The TAP block will be placed using a standardized ultrasound-guided approach. Subjects assigned to the study group will have an injection of 30 mL 0.25% bupivacaine, a local anesthetic with 3 mcg/mL of epinephrine, placed into the plane between the internal oblique and the transversus abdominis

DRUG

Placebo

The placebo block will be placed in a similar manner, using a standardized ultrasound-guided approach. The placebo injection will consist of 30 mL sterile, preservative-free saline.

Trial Locations (1)

53792

University of Wisconsin School of Medicine and Public Health, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01444924 - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery | Biotech Hunter | Biotech Hunter